Clinical Trials Directory

Trials / Completed

CompletedNCT04750980

Microbiota and Allergy

Microbiota as Potential Target for Innovative Preventive and Therapeutic Strategies for Food Allergy

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
48 Months – 84 Months
Healthy volunteers

Summary

Food allergy derives from a dysregulation of oral tolerance mechanisms. Studies suggest a crucial role for gut microbiota in oral tolerance development. An altered composition of gut microbiota results in an unbalanced local and systemic immune response to food allergens. There are qualitative and quantitative differences in gut microbiota composition in children with food allergy. Preliminary results of MATFA study demonstrated gut microbiota in allergic children.These findings support the pivotal role of the gut microbiota in the pathogenesis of allergic diseases and may open new strategies in the development of innovative preventive and therapeutic approaches.

Conditions

Interventions

TypeNameDescription
OTHERfood allergyfood allergy
OTHERrespiratory allergyrespiratory allergy
OTHERhealthy controlshealthy controls

Timeline

Start date
2017-06-01
Primary completion
2021-01-30
Completion
2021-01-30
First posted
2021-02-11
Last updated
2021-07-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04750980. Inclusion in this directory is not an endorsement.